Cover Image
Market Research Report

Global Biodefense Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 938108
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Biodefense Market 2020-2024
Published: May 15, 2020 Content info: 120 Pages
Description

Technavio has been monitoring the biodefense market and it is poised to grow by $ 3.22 billion during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on biodefense market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing threat of bioterrorism, rapid increase in government funding in R&D and recent outbreaks of infectious diseases. In addition, growing threat of bioterrorism is anticipated to boost the growth of the market as well.

The biodefense market analysis includes application segment and geographic landscapes

Technavio's ‘biodefense market ’ is segmented as below:

By Application:

  • Anthrax
  • Smallpox
  • Botulism
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the government initiatives as one of the prime reasons driving the biodefense market growth during the next few years. Also, growing collaborations and M&A and increasing healthcare expenditure will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our biodefense market covers the following areas:

  • Biodefense market sizing
  • Biodefense market forecast
  • Biodefense market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biodefense market vendors that include Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc. Also, the biodefense market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR43768

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Anthrax - Market size and forecast 2019-2024
  • Smallpox - Market size and forecast 2019-2024
  • Botulism - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Alexeter Technologies LLC
  • Alnylam Pharmaceuticals Inc.
  • Altimmune Inc.
  • ANP Technologies Inc.
  • Bavarian Nordic AS
  • Cleveland BioLabs Inc.
  • Elusys Therapeutics Inc.
  • Emergent BioSolutions Inc.
  • General Dynamics Corp.
  • GlaxoSmithKline Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Anthrax - Market size and forecast 2019-2024 ($ million)
  • 24: Anthrax - Year-over-year growth 2019-2024 (%)
  • 25: Smallpox - Market size and forecast 2019-2024 ($ million)
  • 26: Smallpox - Year-over-year growth 2019-2024 (%)
  • 27: Botulism - Market size and forecast 2019-2024 ($ million)
  • 28: Botulism - Year-over-year growth 2019-2024 (%)
  • 29: Others - Market size and forecast 2019-2024 ($ million)
  • 30: Others - Year-over-year growth 2019-2024 (%)
  • 31: Market opportunity by Application
  • 32: Customer landscape
  • 33: Market share by geography 2019-2024 (%)
  • 34: Geographic comparison
  • 35: North America - Market size and forecast 2019-2024 ($ million)
  • 36: North America - Year-over-year growth 2019-2024 (%)
  • 37: Europe - Market size and forecast 2019-2024 ($ million)
  • 38: Europe - Year-over-year growth 2019-2024 (%)
  • 39: Asia - Market size and forecast 2019-2024 ($ million)
  • 40: Asia - Year-over-year growth 2019-2024 (%)
  • 41: ROW - Market size and forecast 2019-2024 ($ million)
  • 42: ROW - Year-over-year growth 2019-2024 (%)
  • 43: Key leading countries
  • 44: Market opportunity by geography ($ million)
  • 45: Impact of drivers and challenges
  • 46: Vendor landscape
  • 47: Landscape disruption
  • 48: Industry risks
  • 49: Vendors covered
  • 50: Market positioning of vendors
  • 51: Alexeter Technologies LLC - Overview
  • 52: Alexeter Technologies LLC - Product and service
  • 53: Alexeter Technologies LLC - Key offerings
  • 54: Alexeter Technologies LLC - Key customers
  • 55: Alexeter Technologies LLC - Segment focus
  • 56: Alnylam Pharmaceuticals Inc. - Overview
  • 57: Alnylam Pharmaceuticals Inc. - Product and service
  • 58: Alnylam Pharmaceuticals Inc. - Key offerings
  • 59: Alnylam Pharmaceuticals Inc. - Key customers
  • 60: Alnylam Pharmaceuticals Inc. - Segment focus
  • 61: Altimmune Inc. - Overview
  • 62: Altimmune Inc. - Business segments
  • 63: Altimmune Inc. - Key offerings
  • 64: Altimmune Inc. - Key customers
  • 65: Altimmune Inc. - Segment focus
  • 66: ANP Technologies Inc. - Overview
  • 67: ANP Technologies Inc. - Product and service
  • 68: ANP Technologies Inc. - Key offerings
  • 69: ANP Technologies Inc. - Key customers
  • 70: ANP Technologies Inc. - Segment focus
  • 71: Bavarian Nordic AS - Overview
  • 72: Bavarian Nordic AS - Business segments
  • 73: Bavarian Nordic AS - Key offerings
  • 74: Bavarian Nordic AS - Key customers
  • 75: Bavarian Nordic AS - Segment focus
  • 76: Cleveland BioLabs Inc. - Overview
  • 77: Cleveland BioLabs Inc. - Product and service
  • 78: Cleveland BioLabs Inc. - Key offerings
  • 79: Cleveland BioLabs Inc. - Key customers
  • 80: Cleveland BioLabs Inc. - Segment focus
  • 81: Elusys Therapeutics Inc. - Overview
  • 82: Elusys Therapeutics Inc. - Product and service
  • 83: Elusys Therapeutics Inc. - Key offerings
  • 84: Elusys Therapeutics Inc. - Key customers
  • 85: Elusys Therapeutics Inc. - Segment focus
  • 86: Emergent BioSolutions Inc. - Overview
  • 87: Emergent BioSolutions Inc. - Business segments
  • 88: Emergent BioSolutions Inc. - Key offerings
  • 89: Emergent BioSolutions Inc. - Key customers
  • 90: Emergent BioSolutions Inc. - Segment focus
  • 91: General Dynamics Corp. - Overview
  • 92: General Dynamics Corp. - Business segments
  • 93: General Dynamics Corp. - Key offerings
  • 94: General Dynamics Corp. - Key customers
  • 95: General Dynamics Corp. - Segment focus
  • 96: GlaxoSmithKline Plc - Overview
  • 97: GlaxoSmithKline Plc - Business segments
  • 98: GlaxoSmithKline Plc - Key offerings
  • 99: GlaxoSmithKline Plc - Key customers
  • 100: GlaxoSmithKline Plc - Segment focus
  • 101: Currency conversion rates for US$
  • 102: Research Methodology
  • 103: Validation techniques employed for market sizing
  • 104: Information sources
  • 105: List of abbreviations
Back to Top